Phoenix Nuclear Labs

Press Release

SHINE Invited to Present at 2017 DOE/NNSA Mo-99 Topical Meeting

September 1st, 2017 | Filed under: Press Release

Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2017 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security Administration (DOE/NNSA).

SHINE Breaks Ground on Building One

August 4th, 2017 | Filed under: Press Release

Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, held a groundbreaking ceremony yesterday to celebrate the start of construction on Building One.

2017 Best of Monona Award

July 14th, 2017 | Filed under: Press Release

MONONA July 6, 2017 — Phoenix Nuclear Labs has been selected for the 2017 Best of Monona Award in the Business Services category by the Monona Award Program.

PNL to supply technology for low cost solar

April 25th, 2017 | Filed under: Press Release

Monona, Wis. – Phoenix Nuclear Labs (PNL) has signed a long-term agreement to be the exclusive supplier of high current proton accelerators to California-based Rayton Solar to produce low cost, high efficiency solar panels. Under the terms of the agreement, PNL will deliver the first system to Rayton at the end of 2017, followed by several additional units in 2018 and 2019.

Martyn Coombs to Advise SHINE

March 27th, 2017 | Filed under: Press Release

Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Martyn Coombs will become a Strategic Adviser to SHINE, on a part-time basis. The announcement comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly-99) and other medical isotopes used to detect and treat a wide variety of diseases, including heart disease and cancer.

Gregory OD Smith Joins SHINE’s Board of Directors

February 13th, 2017 | Filed under: Press Release

Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that Gregory OD Smith will join its Board of Directors. The appointment comes as the company prepares to build its facility in Janesville, Wisconsin, after receiving its construction permit from the U.S. Nuclear Regulatory Commission last year. The SHINE facility will produce molybdenum-99 (moly-99) and other medical isotopes.

SHINE Awarded $20.9 million DOE/NNSA Phase II Cooperative Agreement

December 14th, 2016 | Filed under: Press Release

Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based medical isotope company, announced today that it has been awarded $10 million from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) as part of a $20.9 million cooperative agreement. The Phase II funding was awarded through the DOE/NNSA’s molybdenum-99 (moly-99) program, which works to support the establishment of domestic, commercial production of moly-99 produced without the use of highly-enriched uranium.

SHINE Medical Technologies to Present at Piper Jaffray Healthcare Conference

November 21st, 2016 | Filed under: Press Release

Monona, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 28th Annual Piper Jaffray Healthcare Conference in New York. SHINE’s CEO, Greg Piefer, will present on Wednesday, November 30th at 10:10 a.m. Eastern Time.

SHINE Medical Technologies to Move Headquarters to Janesville, Wisconsin

September 22nd, 2016 | Filed under: Press Release

Monona, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced plans to move its headquarters from Monona to downtown Janesville, Wisconsin late this year. SHINE employees will continue operations in the new headquarters while the company prepares for construction of its medical radioisotope production facility, which was approved by the U.S. Nuclear Regulatory Commission in February.

SHINE to Present at DOE/NNSA Mo-99 Topical Meeting Next Week

September 6th, 2016 | Filed under: Press Release

Monona, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the company has been invited to speak at the 2016 Mo-99 Topical Meeting hosted by the Department of Energy’s National Nuclear Security Administration (DOE/NNSA).